王晓曈,李 杰,刘 瑞.非小细胞肺癌患者血清CA125水平与疾病进展时间的相关性[J].中国肿瘤,2012,21(2):150-152. |
非小细胞肺癌患者血清CA125水平与疾病进展时间的相关性 |
Correlation Between Serum CA125 and Time to Progression(TTP) in Patient with Non-small Cell Lung Caner |
投稿时间:2011-08-01 |
DOI: |
|
 |
中文关键词: 非小细胞肺癌 糖类抗原125 疾病进展时间 预后 |
英文关键词:non-small cell lung cancer CA125 time to progression prognosis |
基金项目:国家自然科学基金(81072802) |
|
摘要点击次数: 2001 |
全文下载次数: 1104 |
中文摘要: |
摘 要:[目的]评价非小细胞肺癌(NSCLC)患者血清糖类抗原(CA125)水平与疾病进展时间(TTP)的关系。[方法]对中国中医科学院广安门医院2006年10月~2009年10月收治的154例非小细胞肺癌患者的血清CA125水平与疾病进展时间的相关性进行回顾性研究。[结果]血清CA125水平与临床分期相关,Ⅳ期患者血清CA125水平明显高于ⅢB期(P<0.05)。血清CA125水平≥123U/ml的患者半年内进展的风险比CA125水平<123U/ml的患者增加89%(OR=1.889,95%CI:1.254~2.845,P=0.002)。[结论] 血清CA125水平与患者疾病进展时间有明显的相关性,可通过检测CA125水平判断患者预后。 |
英文摘要: |
Abstract: [Purpose]To analyze the correlation between serum CA125 and time to progression (TTP) in the patients with non-small cell lung cancer (NSCLC). [Methods] Retrospective study on the correlation between serum CA125 and TTP was conducted in 154 NSCLC cases from Guang’anmen Hospital, China Academy of Chinese Medical Science. [Results] The level of serum CA125 in patients with stage Ⅳ was significantly higher than that in those with stageⅢB (P<0.05). In term of tumour progress risk in 6 months, the patients with a high level of serum CA125 (≥123U/ml) had 89% higher risk than patients with a low level of serum CA125 (<123U/ml) (P=0.002). [Conclusion] There is obvious correlation between the serum level of CA125 and TTP in patients with NSCLC. The serum level of CA125 is a helpful prognostic index, which is especially valuable to evaluate prognosis and to establish the clinical therapeutic project. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|